Literature DB >> 18540644

Why is chitosan mucoadhesive?

Ioannis A Sogias1, Adrian C Williams, Vitaliy V Khutoryanskiy.   

Abstract

Chitosan is a biocompatible and biodegradable amino polysaccharide, which is soluble in aqueous solutions at pH < 6.5. It has been widely used for developing drug delivery systems because of its excellent mucoadhesive properties. Although many studies report on chitosan being mucoadhesive, the nature of interactions between chitosan and mucin remains poorly defined. Here, we have examined the role of primary amino groups and the role of electrostatic attraction, hydrogen bonding, and hydrophobic effects on aggregation of gastric mucin in the presence of chitosan. Reducing the number of amino groups through their half acetylation results in expansion of chitosan's pH-solubility window up to pH 7.4 but also reduces its capacity to aggregate mucin. We demonstrated that electrostatic attraction forces between chitosan and gastric mucin can be suppressed in the presence of 0.2 mol/L sodium chloride; however, this does not prevent the aggregation of mucin particles in the presence of this biopolymer. The presence of 8 mol/L urea or 10% v/v ethanol in solutions also affects mucin aggregation in the presence of chitosan, demonstrating the role of hydrogen bonding and hydrophobic effects, respectively, in mucoadhesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540644     DOI: 10.1021/bm800276d

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  77 in total

1.  Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Dipak K Majumdar
Journal:  J Mater Sci Mater Med       Date:  2010-06-10       Impact factor: 3.896

2.  The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.

Authors:  Bénédicte Petit; Kawthar Bouchemal; Christine Vauthier; Madeleine Djabourov; Gilles Ponchel
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

Review 3.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

4.  Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan.

Authors:  Amjad Alhalaweh; Annamaria Vilinska; Elisabetta Gavini; Giovanna Rassu; Sitaram P Velaga
Journal:  AAPS PharmSciTech       Date:  2011-09-15       Impact factor: 3.246

5.  Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.

Authors:  Katelyn P Reighard; Camille Ehre; Zachary L Rushton; Mona Jasmine R Ahonen; David B Hill; Mark H Schoenfisch
Journal:  ACS Biomater Sci Eng       Date:  2017-05-15

6.  A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.

Authors:  Shaswath S Chandrasekar; Brock Kingstad-Bakke; Chia-Wei Wu; M Suresh; Adel M Talaat
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 7.  Advances and limitations of drug delivery systems formulated as eye drops.

Authors:  Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

8.  Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin.

Authors:  Pedro Fonte; Tiago Nogueira; Christiane Gehm; Domingos Ferreira; Bruno Sarmento
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

Review 9.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

10.  Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.

Authors:  Wanachat Chaiyasan; Sangly P Srinivas; Waree Tiyaboonchai
Journal:  J Ocul Pharmacol Ther       Date:  2013-01-28       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.